首页> 美国卫生研究院文献>The Journal of Physiology >Enhancement by atropine of the pancreatic exocrine secretions evoked by vagal stimulation in the pithed rat.
【2h】

Enhancement by atropine of the pancreatic exocrine secretions evoked by vagal stimulation in the pithed rat.

机译:阿托品对迷迭香大鼠迷走神经刺激引起的胰腺外分泌分泌的增强作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. Pancreatic secretions were collected in response to 15 min periods of bilateral stimulation of the cervical vagus nerves in the pithed rat. 2. The weight of juice, total HCO3- and total protein evoked by a second period of vagal stimulation were essentially similar to those of the first period of vagal stimulation. 3. When the second period of vagal stimulation was preceded by an intravenous bolus injection of atropine sufficient to block the vagally induced bradycardia, the weight of secretion and total protein were greatly potentiated over an extended time course far exceeding that of the period of vagal stimulation. Total HCO3- was unchanged. 4. By contrast, atropine was effective in antagonizing the stimulatory effects of the muscarinic agonist methacholine injected intravenously. 5. The putative VIP (vasoactive intestinal polypeptide) antagonist [D-p-chloro-Phe6, Leu17]-VIP injected intravenously also increased the vagally evoked weight of juice, with total HCO3- and total protein unchanged. This was explicable by a partial agonist effect which was additive to the stimulatory action of vagal stimulation. 6. To explain these results, it is proposed that endogenously released acetylcholine exerts a negative feedback effect on the postganglionic varicosities which release both acetylcholine and another cotransmitter which was not excluded as being VIP. In the presence of atropine, the cotransmitter is proposed to be released from the inhibitory feedback, thus enhancing the response to vagal stimulation.
机译:1.在15分钟的双侧刺激大鼠的颈迷走神经后收集胰腺分泌物。 2.迷走神经刺激的第二阶段所诱发的汁液重量,总HCO3-和总蛋白质与迷走神经刺激的第一阶段基本相似。 3.在迷走神经刺激的第二阶段之前,静脉内推注阿托品足以阻断迷走神经引起的心动过缓,在一段较长的时间内,分泌和总蛋白的重量会大大增强,远远超过迷走神经刺激的时间。总HCO3-保持不变。 4.相比之下,阿托品有效拮抗静脉注射毒蕈碱激动剂乙酰甲胆碱的刺激作用。 5.静脉注射推定的VIP(血管活性肠多肽)拮抗剂[D-p-chloro-Phe6,Leu17] -VIP也增加了阴道诱发的汁液重量,总HCO3-和总蛋白质不变。这可以通过部分激动剂作用来解释,该激动剂作用于迷走神经刺激的刺激作用。 6.为解释这些结果,建议内源性释放的乙酰胆碱对神经节后静脉曲张产生负反馈作用,该神经节后静脉曲张同时释放乙酰胆碱和另一种不被视为VIP的共递质。在存在阿托品的情况下,建议从抑制性反馈中释放共递质,从而增强对迷走神经刺激的反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号